Christopher Chapman

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Christopher Chapman, Jr., MD
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Chapman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Telomir Pharmaceuticals, Inc. CEO & Chairman, Director Common Stock 976K $6.05M $6.20 Feb 8, 2024 Direct
MyMD Pharmaceuticals, Inc. President, Chief Med. Officer, Director Employee Stock Option (Right to Buy) 300K Jun 7, 2023 Direct
MIRA PHARMACEUTICALS, INC. Executive Chairman, Director Stock Options 50K Aug 17, 2023 Direct

Insider Reports Filed by Christopher Chapman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TELO Telomir Pharmaceuticals, Inc. Feb 8, 2024 0 $0 3 Feb 8, 2024 CEO & Chairman, Director
MIRA MIRA PHARMACEUTICALS, INC. Aug 17, 2023 1 $0 4 Aug 21, 2023 Executive Chairman, Director
MIRA MIRA PHARMACEUTICALS, INC. Aug 2, 2023 0 $0 3 Aug 2, 2023 Executive Chairman, Director
MYMD MyMD Pharmaceuticals, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 President, Chief Med. Officer, Director
MYMD MyMD Pharmaceuticals, Inc. Apr 4, 2023 1 $0 4 Apr 5, 2023 President, Chief Med. Officer, Director
MYMD MyMD Pharmaceuticals, Inc. Oct 14, 2021 1 $0 4 Oct 15, 2021 President, Chief Med. Officer, Director